Purpose Patients with differentiated thyroid cancer (DTC) typically have a favourable
prognosis and recurrence as late as 45 years after diagnosis has been reported …

Objective Because differentiated (follicular and papillary) thyroid cancer (DTC) may recur
years after initial treatment, the follow-up of patients with DTC is long term. However, this …

Active Surveillance is a non-invasive strategy designed to identify a minority of patients with
low-risk papillary thyroid carcinoma who might experience clinical progression and benefit …

Each year, the proportion of thyroid cancer patients presenting with low-risk disease is
increasing. The shift in the landscape of thyroid cancer presentation is forcing clinicians to re …

The indolent nature and favorable outcomes associated with papillary thyroid
microcarcinoma have prompted numerous prospective studies on active surveillance (AS) …

The treatment paradigm for thyroid cancer has shifted from a one-size-fits-all approach to
more personalized protocols that range from active surveillance to total thyroidectomy …

Abstract Background The 2014 British Thyroid Association thyroid cancer guidelines
recommend lifelong follow‐up of all thyroid cancer patients. This is probably unnecessary …

The incidence of thyroid cancer is increasing globally, but mortality rates have remained
steady. Many patients with thyroid cancer have low-risk, nonmetastatic intrathyroidal tumors …

Background The most important part of the follow-up of differentiated thyroid carcinoma
(DTC) is the measurement of serum thyroglobulin (Tg). An increase of Tg levels indicates …

Simple Summary In patients with differentiated thyroid cancer (DTC), the American Thyroid
Association dynamic risk stratification system has been proposed to identify patients at …